Semnur Pharmaceuticals, Inc.
SMNR
$0.84
$0.045.01%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.58M | -6.16M | -152.59M | -999.00K | -665.00K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.48M | 2.03M | 140.19M | 119.00K | 92.00K |
| Change in Net Operating Assets | 422.00K | 521.00K | 10.27M | 1.15M | 174.00K |
| Cash from Operations | -2.67M | -3.61M | -2.13M | 268.00K | -399.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 3.50M | -4.06M | 7.38M | 1.30M | 1.23M |
| Total Debt Repaid | -750.00K | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 7.60M | -5.22M | -1.52M | -836.00K |
| Cash from Financing | 2.75M | 3.54M | 2.16M | -220.00K | 394.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 83.00K | -65.00K | 30.00K | 48.00K | -5.00K |